President's Message
News Release
April 15, 2026
|
Press Release
NEW
Announcement of Launch in Japan of RAVICTI® Oral Liquid 1.1 g/mL
March 24, 2026
|
Press Release
NEW
OrphanPacific Obtains Marketing Approval in Japan for Leniolisib (Joenja®) for the Treatment of APDS for adults and pediatric patients 4 years of age and older
December 22, 2025
|
Press Release
Notice of Marketing Authorization for “RAVICTI® Oral Liquid 1.1 g/mL” for Urea Cycle Disorders
July 25, 2025
|
Press Release
Notice of Head Office Relocation (Change of Building)
December 25, 2024
|
Press Release
Announcement Regarding the Designation of Glycerol Phenylbutyrate as an Orphan Drug
We associate with the activities of Rare Disease Day JAPAN and support activities.
